These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9687426)

  • 1. Confirmatory evidence from 18S rRNA gene analysis for in vivo development of propamidine resistance in a temporal series of Acanthamoeba ocular isolates from a patient.
    Ledee DR; Seal DV; Byers TJ
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2144-5. PubMed ID: 9687426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy.
    Hay J; Kirkness CM; Seal DV; Wright P
    Eye (Lond); 1994; 8 ( Pt 5)():555-63. PubMed ID: 7835453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-resistant severe Acanthamoeba keratitis caused by rare T5 Acanthamoeba genotype.
    Iovieno A; Oechsler RA; Ledee DR; Miller D; Alfonso EC
    Eye Contact Lens; 2010 May; 36(3):183-4. PubMed ID: 20461886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity.
    Pérez-Santonja JJ; Kilvington S; Hughes R; Tufail A; Matheson M; Dart JK
    Ophthalmology; 2003 Aug; 110(8):1593-600. PubMed ID: 12917179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acanthamoeba griffini. Molecular characterization of a new corneal pathogen.
    Ledee DR; Hay J; Byers TJ; Seal DV; Kirkness CM
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):544-50. PubMed ID: 8595954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro study of propamidine isethionate: value in the follow-up of Acanthamoeba amebic keratitis].
    Paniagua-Crespo E; Hasle DP; Aouizerate F; Volant A; Simitzis-Le Flohic AM
    J Fr Ophtalmol; 1989; 12(6-7):489-91. PubMed ID: 2636245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acanthamoeba lenticulata keratitis in a hard contact lens wearer.
    van Zyl LM; Andrew N; Chehade M; Sadlon TA; Badenoch PR
    Clin Exp Ophthalmol; 2013 Nov; 41(8):810-2. PubMed ID: 23448683
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acanthamoeba keratitis treated with propamidine and polyhexamethyl biguanide (PHMB)].
    Donoso R; Mura JJ; López M
    Rev Med Chil; 2002 Apr; 130(4):396-401. PubMed ID: 12090104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine.
    Seal D; Hay J; Kirkness C; Morrell A; Booth A; Tullo A; Ridgway A; Armstrong M
    Eye (Lond); 1996; 10 ( Pt 4)():413-21. PubMed ID: 8944089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent acanthamoeba keratitis in a non-contact lens wearer following exposure to bird seed dust.
    Syam PP; Narendran R; van der Hoek J
    Br J Ophthalmol; 2005 Mar; 89(3):388-9. PubMed ID: 15722327
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acanthamoeba keratitis, a possible dibromo propamidine isethionate resistance].
    Vaquero Ruano M; Encinas Martín JL; Ramón Y Cajal S; Cajigal Morales C
    Arch Soc Esp Oftalmol; 2002 May; 77(5):279-81. PubMed ID: 12023748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluations of topical agents to treat Acanthamoeba keratitis.
    Sunada A; Kimura K; Nishi I; Toyokawa M; Ueda A; Sakata T; Suzuki T; Inoue Y; Ohashi Y; Asari S; Iwatani Y
    Ophthalmology; 2014 Oct; 121(10):2059-65. PubMed ID: 24880905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotypic heterogeneity based on 18S-rRNA gene sequences among Acanthamoeba isolates from clinical samples in Italy.
    Di Cave D; D' Alfonso R; Dussey Comlavi KA; D' Orazi C; Monno R; Berrilli F
    Exp Parasitol; 2014 Nov; 145 Suppl():S46-9. PubMed ID: 24858926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis.
    Elder MJ; Kilvington S; Dart JK
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1059-64. PubMed ID: 8125716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-isolation of Vahlkampfia and acanthamoeba in acanthamoeba-like keratitis in a Spanish population.
    Arnalich-Montiel F; Lorenzo-Morales J; Irigoyen C; Morcillo-Laiz R; López-Vélez R; Muñoz-Negrete F; Piñero JE; Valladares B
    Cornea; 2013 May; 32(5):608-14. PubMed ID: 22929156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy for acanthamoeba keratitis.
    Elder MJ; Dart JK
    Lancet; 1995 Mar; 345(8952):791-2; author reply 792-3. PubMed ID: 7891501
    [No Abstract]   [Full Text] [Related]  

  • 17. Laser in situ keratomileusis treatment for myopia after Acanthamoeba keratitis.
    Lim L; Wei RH
    Eye Contact Lens; 2004 Apr; 30(2):103-4. PubMed ID: 15260359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of In Vitro Antiamoebic Activity of Antimicrobial Agents Against Clinical Acanthamoeba Isolates.
    Nakaminami H; Tanuma K; Enomoto K; Yoshimura Y; Onuki T; Nihonyanagi S; Hamada Y; Noguchi N
    J Ocul Pharmacol Ther; 2017 Oct; 33(8):629-634. PubMed ID: 28704121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Acanthamoeba keratitis.
    Seal D
    Expert Rev Anti Infect Ther; 2003 Aug; 1(2):205-8. PubMed ID: 15482114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe Keratitis Caused by Acanthamoeba Genotype T12 in Thailand: A Case Report.
    Satitpitakul V; Putaporntip C; Jongwutiwes S
    Am J Trop Med Hyg; 2021 Nov; 106(2):681-684. PubMed ID: 34724625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.